Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Interest & Investment Income (2021 - 2026)

Prokidney's (PROK) quarterly Interest & Investment Income came in at $1.9 million in Q2 2026, down 46.06% year-over-year from $3.6 million in Q2 2025, and down 16.72% quarter-over-quarter from $2.3 million in Q1 2026.

Analysis

Prokidney (PROK) Interest & Investment Income (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Interest & Investment Income for 6 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Interest & Investment Income fell 46.06% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $10.5 million, a 41.87% decrease from a year earlier, with the FY2025 full-year figure at $13.8 million, down 30.07% from the prior year.
  • Interest & Investment Income was $1.9 million for Q2 2026 at Prokidney, down from $2.3 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $6.0 million in Q2 2023 and troughed at $1.6 million in Q3 2022.
  • A 5-year average of $4.1 million and a median of $4.5 million in 2022 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income surged 52783.23% in 2022 and slumped 46.06% in 2026, its largest moves.
  • Over 5 years, Interest & Investment Income stood at $4.4 million in 2022, then gained by 19.95% to $5.3 million in 2023, then fell by 9.24% to $4.8 million in 2024, then sank by 38.75% to $2.9 million in 2025, then slumped by 33.97% to $1.9 million in 2026.
  • The last three Interest & Investment Income figures came in at $1.9 million (Q2 2026), $2.3 million (Q1 2026), and $2.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 7.66 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -2.69 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 3.22 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 5.60 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 5.05 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 7.49 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 366,000.00
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 1.95 Mn
10 Prokidney 346.07 Mn 346.07 Mn - 1.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.94 Mn
Mar 31, 2026 2.33 Mn
Dec 31, 2025 2.94 Mn
Sep 30, 2025 3.26 Mn
Jun 30, 2025 3.59 Mn
Mar 31, 2025 4.03 Mn
Dec 31, 2024 4.79 Mn
Sep 30, 2024 5.58 Mn
Jun 30, 2024 4.54 Mn
Mar 31, 2024 4.84 Mn
Dec 31, 2023 5.28 Mn
Sep 30, 2023 5.54 Mn
Jun 30, 2023 5.97 Mn
Mar 31, 2023 5.30 Mn
Dec 31, 2022 4.40 Mn
Sep 30, 2022 1.58 Mn
Dec 31, 2021 8,324.00
Sep 30, 2021 3,042.00